DekaBank Deutsche Girozentrale’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-52,800
Closed -$70K 1425
2022
Q2
$70K Hold
52,800
﹤0.01% 1303
2022
Q1
$111K Buy
52,800
+4,800
+10% +$11.7K ﹤0.01% 1265
2021
Q4
$177K Buy
48,000
+1,500
+3% +$6.46K ﹤0.01% 1287
2021
Q3
$232K Hold
46,500
﹤0.01% 1179
2021
Q2
$294K Hold
46,500
﹤0.01% 1147
2021
Q1
$309K Hold
46,500
﹤0.01% 1114
2020
Q4
$458K Sell
46,500
-2,500
-5% -$16.2K ﹤0.01% 1038
2020
Q3
$170K Buy
+49,000
New +$233K ﹤0.01% 1070

Other funds holding PGEN

DekaBank Deutsche Girozentrale's PGEN Position: Q3 2022 in Review

DekaBank Deutsche Girozentrale sold out of Precigen (PGEN) in Q3 2022, closing a stake of 52,800 shares — an estimated $70K sold.

DekaBank Deutsche Girozentrale first reported a position in PGEN in Q3 2020 and held it in 8 quarters. The position peaked at $458K in Q4 2020. 165 funds tracked by Wall St. Rank hold PGEN as of Q3 2022.

  • DekaBank Deutsche Girozentrale reported no remaining Precigen position as of Q3 2022 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 52,800 Precigen shares in Q3 2022, an estimated $70K.
  • DekaBank Deutsche Girozentrale first reported a position in Precigen in Q3 2020 and held it in 8 quarters.
  • DekaBank Deutsche Girozentrale's Precigen position peaked at $458K in Q4 2020.
  • 165 funds tracked by Wall St. Rank held Precigen as of Q3 2022.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2022, filed 2 Nov 2022.